LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 6 of 15: Mean cell count and mean growth rate across biological replicate 3. - Dataset (ID:20242)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
BT-20 | JW-7-24-1 | 0.12 | uM | LJP6 | 72 | hr | 1097 | 3059 | 3769 | 0.8115 | 0.7341 |
BT-20 | Lapatinib | 0.12 | uM | LJP6 | 72 | hr | 1097 | 3280 | 3769 | 0.8703 | 0.8171 |
BT-20 | LDN-193189 | 0.12 | uM | LJP5 | 72 | hr | 1097 | 3388 | 3769 | 0.8989 | 0.8574 |
BT-20 | Linifanib | 0.12 | uM | LJP6 | 72 | hr | 1097 | 3763 | 3769 | 0.9983 | 0.9976 |
BT-20 | Linsitinib | 0.12 | uM | LJP5 | 72 | hr | 1097 | 3616 | 3769 | 0.9593 | 0.9425 |
BT-20 | Mitoxantrone | 0.12 | uM | LJP5 | 72 | hr | 1097 | 1136 | 3769 | 0.3014 | 0.0145 |
BT-20 | Mitoxantrone | 0.12 | uM | LJP6 | 72 | hr | 1097 | 1149 | 3769 | 0.3050 | 0.0196 |
BT-20 | MK2206 | 0.12 | uM | LJP6 | 72 | hr | 1097 | 2986 | 3769 | 0.7923 | 0.7070 |
BT-20 | Neratinib | 0.12 | uM | LJP5 | 72 | hr | 1097 | 2626 | 3769 | 0.6968 | 0.5723 |
BT-20 | Nilotinib | 0.12 | uM | LJP5 | 72 | hr | 1097 | 4002 | 3769 | 1.0618 | 1.0872 |
BT-20 | Nintedanib | 0.12 | uM | LJP6 | 72 | hr | 1097 | 3389 | 3769 | 0.8992 | 0.8579 |
BT-20 | NU7441 | 0.12 | uM | LJP5 | 72 | hr | 1097 | 3754 | 3769 | 0.9959 | 0.9942 |
BT-20 | Dactolisib | 0.12 | uM | LJP5 | 72 | hr | 1097 | 1098 | 3769 | 0.2913 | 0.0003 |
BT-20 | NVP-TAE684 | 0.12 | uM | LJP6 | 72 | hr | 1097 | 3679 | 3769 | 0.9762 | 0.9664 |
BT-20 | Palbociclib | 0.12 | uM | LJP6 | 72 | hr | 1097 | 1959 | 3769 | 0.5197 | 0.3225 |
BT-20 | PD0325901 | 0.12 | uM | LJP5 | 72 | hr | 1097 | 3094 | 3769 | 0.8209 | 0.7473 |
BT-20 | PD0325901 | 0.12 | uM | LJP6 | 72 | hr | 1097 | 3152 | 3769 | 0.8363 | 0.7690 |
BT-20 | PD173074 | 0.12 | uM | LJP6 | 72 | hr | 1097 | 3999 | 3769 | 1.0609 | 1.0859 |
BT-20 | PD184352 | 0.12 | uM | LJP5 | 72 | hr | 1097 | 3927 | 3769 | 1.0419 | 1.0592 |
BT-20 | Pelitinib | 0.12 | uM | LJP5 | 72 | hr | 1097 | 3065 | 3769 | 0.8132 | 0.7365 |
BT-20 | PF431396 | 0.12 | uM | LJP5 | 72 | hr | 1097 | 2975 | 3769 | 0.7894 | 0.7029 |
BT-20 | PF477736 | 0.12 | uM | LJP5 | 72 | hr | 1097 | 3621 | 3769 | 0.9606 | 0.9444 |
BT-20 | PF562271 | 0.12 | uM | LJP6 | 72 | hr | 1097 | 3400 | 3769 | 0.9021 | 0.8620 |
BT-20 | PHA-665752 | 0.12 | uM | LJP5 | 72 | hr | 1097 | 3713 | 3769 | 0.9852 | 0.9791 |
BT-20 | PHA-793887 | 0.12 | uM | LJP6 | 72 | hr | 1097 | 2010 | 3769 | 0.5333 | 0.3417 |